Nymox Pharmaceutical
NYMX
#8008
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-53.49%
Change (1 year)
Categories
Earnings for Nymox Pharmaceutical (NYMX)
Earnings in 2023 (TTM): -$2.17 M
According to Nymox Pharmaceutical's latest financial reports the company's current earnings (TTM) are -$2.17 M. In 2022 the company made an earning of -$6.53 M an increase over its 2021 earnings that were of -$12.49 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Nymox Pharmaceutical from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$2.17 M | -66.89% |
| 2022 | -$6.53 M | -47.71% |
| 2021 | -$12.49 M | 6.61% |
| 2020 | -$11.71 M | -10.91% |
| 2019 | -$13.14 M | 24.24% |
| 2018 | -$10.58 M | -20.03% |
| 2017 | -$13.23 M | 2.71% |
| 2016 | -$12.88 M | -63.86% |
| 2015 | -$35.64 M | 674.44% |
| 2014 | -$4.61 M | -6.11% |
| 2013 | -$4.91 M | |
| 2011 | -$9.62 M | 38.33% |
| 2010 | -$6.95 M | 35.59% |
| 2009 | -$5.13 M | 11.8% |
| 2008 | -$4.59 M | -12.94% |
| 2007 | -$5.27 M | 8.85% |
| 2006 | -$4.84 M | 36.5% |
| 2005 | -$3.55 M | -4.4% |
| 2004 | -$3.71 M | -14.58% |
| 2003 | -$4.34 M | |
| 2001 | -$3.19 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -785,477.14% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -151,280.01% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.66 B | -308,475.75% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | -303,413.28% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $1.13 B | -52,390.61% | 🇺🇸 USA |